For science, to create a vaccine against the Human Immunodeficiency Virus (HIV) stays the largest challenges.

Scientists now have a lot of knowledge about the HIV virus and how it causes AIDS ever since it was discovered. But in order to create a vaccine to stop the virus has been a huge challenge for the scientists, said the International AIDS Vaccine Initiative (IAVI) in a statement to mark World AIDS Vaccine Day.

“With 7,400 people newly infected with HIV every day, the best hope we have of ending this human catastrophe is to develop and widely distribute effective vaccines against the virus,” Seth Berkeley, CEO and founder of IAVI, said.

According to the statement, last September, an applicant vaccine routine tested in a huge clinical experiment in Thailand cosseted volunteers from HIV with 30% effectiveness. The result thrilled the field: it was found to be the first display in humans that an AIDS vaccine proved promising.

The statement said that consequently, scientist associated with IAVI and the U. S. National Institutes of Health have revealed still more largely neutralising antibodies to HIV.

Also, it has been said in the statement that HIV scientists must tie together the most up-to-date scientific perspectives and technical gears to create potentially more capable HIV vaccine candidate for human experiments.